* Ciba Specialty Chemicals, the spin-off company from the Novartis merger, has set up a $2bn Euro-MTN programme, signalling the arrival of the recently formed company in the international capital markets. Set up at the beginning of this year, Ciba Specialty Chemicals has moved quickly to establish its credentials in the market, taking out a Sfr1.5bn syndicated loan and seeking ratings from international ratings agencies. Setting up a Euro-MTN programme was the next logical step, it said.
September 26, 1997